{"id":"F2007B01048","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 2 of 2000)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-2-of-2000","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":62524,"registerId":"commonwealth-F2007B01048-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 2 of 2000)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 2 of 2000\n\nI, ALAN WILLIAM STEVENS, Acting Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Aged Care and Delegate of the Minister for Health and Aged Care, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1.  This Declaration shall come into operation on 1 February 2000.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nGrepafloxacin Hydrochloride Sesquihydrate\n\nOmeprazole and Metronidazole and Amoxycillin Trihydrate\n\n“RVHB Maxamaid”\n\nVidarabine\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\nDated this 31st day of December 1999.\n\nALAN WILLIAM STEVENS\n\nActing Assistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Aged Care\n\nDelegate of the Minister for Health and Aged Care","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1774},"content_quality":"ok","complexity_score":2,"rejection_reason":"","scope_assessment":{"changed":false,"description":"This is the original declaration as made in 1999; it has not expanded beyond its initial purpose of removing four specified pharmaceutical products from PBS coverage."},"complexity_factors":["Single operative provision with no subsections, exceptions, or conditions","Schedule contains only four specific items with no technical elaboration","No defined terms or interpretative clauses within the instrument","Legal effect depends on external knowledge of Part VII of the National Health Act 1953 (the PBS framework)"],"plain_english_summary":"This declaration removes four medicines—grepafloxacin hydrochloride sesquihydrate; a combination pack of omeprazole, metronidazole and amoxycillin trihydrate; RVHB Maxamaid; and vidarabine—from Australia’s Pharmaceutical Benefits Scheme, ending government subsidy for their PBS prescriptions. Patients and prescribers must pay private prices or use alternatives.\n\nThe change, advised by the Pharmaceutical Benefits Advisory Committee and enacted by a senior health department official on the Minister’s behalf, took effect 1 February 2000."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-2-of-2000","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-2-of-2000/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-2-of-2000/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-2-of-2000/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-2-of-2000/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-2-of-2000/documents"}}